B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Clinical trial NCT04897321 · RECRUITING

Trial details

NCT number: NCT04897321
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Solid Tumor Osteosarcoma Rhabdomyosarcoma Neuroblastoma Ewing Sarcoma Wilms Tumor Adrenocortical Cancer Desmoplastic Small Round Cell Tumor Germ Cell Cancer Rhabdoid Tumor Clear Cell Sarcoma Hepatoblastoma

Start date: 2022-07-06
Primary completion: 2027-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.